Business Wire

  1. BIOTECHNICA AMERICA, INTERPHEX And PharmaMedDevice Host Joint Life Sciences Event In New York For The First Time 11/6/2008
    BIOTECHNICA, the biggest biotechnology show in Europe, America's top pharmaceuticals show INTERPHEX and PharmaMedDevice, an event which focuses on combination products(pharma/medical devices), will be joining forces again in 2009 to showcase their expertise.
  2. World's Largest Companies Keep Making Bets On Nanotech 11/6/2008
    With nanotechnology shifting from an emphasis on R&D to a focus on commercialization – with $147 billion worth of products enabled by nanotech sold in 2007 – the strategies of global corporations and start-ups working on nanotechnology have shifted, according to a new report by Lux Research.
  3. JMP® Genomics, NCGR Partnership To Foster Development Of Next-Gen Sequencing Tools 11/6/2008
    A new strategic partnership between SAS and the National Center for Genome Resources (NCGR) will strengthen ongoing collaboration between JMP and NCGR for the co-development of software tools for next-generation sequencing data analysis.
  4. Stanford Research Sheds Light On Key Trigger Of Embryonic Stem Cell Differentiation 11/5/2008
    Clusters of mouse embryonic stem cells called embryoid bodies more closely approximate true embryos in organization and structure than previously thought, according to researchers at the Stanford University School of Medicine.
  5. Millipore And Applikon Biotechnology Form Collaboration To Expand Offerings In Fast-Growing Disposable Manufacturing Market 11/4/2008
    Millipore Corporation and Applikon Biotechnology B.V. today announced an agreement to co-develop and distribute disposable bioreactor systems for biopharmaceutical applications.
  6. StemCells, Inc. Announces Preclinical Results Showing Its Proprietary Human Neural Stem Cells Can Prevent Vision Loss 10/30/2008
    StemCells, Inc.reported today that its proprietary HuCNS-SC® product candidate (purified human neural stem cells), when transplanted into a well-established animal model, can protect the retina from progressive degeneration.
  7. Phenomix Initiates Phase 1a Clinical Trial of Hepatitis C Protease Inhibitor 10/28/2008
    In this double-blind, randomized, placebo-controlled Phase 1a study, subjects will be treated with single ascending doses of PHX1766 in order to assess safety, tolerability and pharmacokinetics. Additionally, reductions in viral load will be measured in the patients with HCV infection.
  8. Applied Biosystems Stockholders Approve Merger With Invitrogen 10/28/2008
    Applied Biosystems Inc. (NYSE:ABI) today announced that its stockholders have voted to approve the company’s proposed merger with Invitrogen Corporation (NASDAQ:IVGN) at a special meeting of stockholders held today.
  9. Dune Medical Launches US FDA Cleared Clinical Trial For Use Of MarginProbe In Breast Cancer Surgery 10/27/2008
    Dune Medical Devices, Ltd. today announced the launch of a pivotal clinical trial of the MarginProbe™ intraoperative, real-time, positive margin detection system, following U.S. Food and Drug Administration (FDA) investigational device exemption (IDE) approval of its protocol during breast cancer surgery.
  10. What Would You Do With a $10K Genome? 10/27/2008
    As part of its commitment to promote basic research in the life sciences, Applied Biosystems Inc. (NYSE:ABI) today announced the creation of a grant program for genomic, epigenomic and transcriptome studies.